Trevi Therapeutics Inc (TRVI)

$2.77 0.00 (0.00%)

16:00 EDT TRVI Stock Quote Delayed 30 Minutes

TRVI Stock Earnings: Trevi Therapeutics Misses EPS for Q1 2024

By InvestorPlace Earnings May 7, 2024

TRVI stock results show that Trevi Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

TRVI Stock Earnings: Trevi Therapeutics Beats EPS for Q4 2023

5 Penny Stocks to Buy on the Dip

Trevi Therapeutics (TRVI) Stock Spikes 20% on Positive Clinical Data

More Articles

Volume:

Previous Close -

Market Cap 166.09M

PE Ratio -10.63

EPS -0.26

Volume (Avg. Vol.)

Day's Range -

52-Week Range $0.97 - $4.00

Dividend & Yield N/A (N/A)

TRVI Stock Predictions, Articles, and Trevi Therapeutics Inc News

From InvestorPlace
From the Web

Why Is Trevi Therapeutics (TRVI) Stock On the Move Today?

By William White, InvestorPlace Writer Apr 8, 2022

Trevi Therapeutics (TRVI) stock is slipping on Friday but that's only after the biopharmaceutical company saw a massive rally yesterday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Mar 3, 2022

Good morning! In preparation for another busy day of trading, we've put together a list of the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Oct 12, 2021

Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Tuesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Oct 11, 2021

Welcome back, traders! We're kicking off the week right with a look at the biggest pre-market stock market movers for Monday!

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Trevi Therapeutics (TRVI) and Sight Sciences (SGHT)

From TipRanks Nov 11, 2022

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Trevi Therapeutics (

Trevi Therapeutics (TRVI) Gets a Buy from Needham

From TipRanks Sep 20, 2022

Needham analyst Serge Belanger maintained a Buy rating on Trevi Therapeutics (TRVI – Research Report) today and set a price target of $10.00. The company&#821...

Needham Reaffirms Their Buy Rating on Trevi Therapeutics (TRVI)

From TipRanks Aug 12, 2022

In a report released today, Serge Belanger from Needham maintained a Buy rating on Trevi Therapeutics (TRVI – Research Report), with a price target of $10.00....

These 2 Penny Stocks Have Over 300% Upside on the Horizon, Says Oppenheimer

From TipRanks Jun 23, 2022

Earlier this month, the SP 500 officially entered a bear market; its current year-to-date loss stands at 21%, and the NASDAQ, which has fallen faster and farth...

Recap: Trevi Therapeutics Q1 Earnings

From Benzinga May 12, 2022

Trevi Therapeutics (NASDAQ:TRVI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

34 Stocks Moving In Monday's Mid-Day Session

From Benzinga Apr 18, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions....

ADVERTISEMENT